Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,760.00    30.00 (1.10%)
Bid:
2,760.00
Ask:
2,785.00
Spread: 25.00 (0.906%)
Market Cap: £1.31b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Transaction in Own Shares

17 Sep 2019 18:00

RNS Number : 6788M
RHI Magnesita N.V.
17 September 2019
 

RHI Magnesita N.V.

("RHI Magnesita" or the "Company")

 

Transaction in own shares

 

RHI Magnesita N.V. (the "Company") announces that on 17 September 2019 it purchased the following number of its ordinary shares, represented by depositary interests ("Shares") of one euro nominal value each pursuant to its £20 million share repurchase programme to satisfy awards made under employee performance share plans, details of which were announced on 12 August 2019 (the "Programme").

 

Description of Shares: RHI Magnesita N.V. - ordinary shares represented by depositary interests of one euro nominal value each

Number of Shares repurchased: 14,143 Shares

Date of transaction: 17/09/2019

Time of transaction: 08:09 - 16:29

Volume weighted average price paid per Share: 4,233.2500 pence

Lowest price paid per Share: 4,202.0 pence

Highest price paid per Share: 4,268.0 pence

Venue: XLON

Broker: Barclays Capital Securities Limited

Total number of Shares repurchased pursuant to the Programme to date: 350,059 Shares

 

The Company intends to hold the purchased Shares in treasury. Following the purchase of these Shares, the remaining number of Shares in issue will be 49,127,646 Shares (excluding treasury shares), and the Company will hold 350,059 Shares in Treasury.

The figure of 49,127,646 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases is attached to this announcement. 

http://www.rns-pdf.londonstockexchange.com/rns/6788M_1-2019-9-17.pdf

 

For further enquiries, please contact:

Guy Marks, Head of Investor Relations

Tel +44 7932 013 357

E‐mail: guy.marks@rhimagnesita.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are indispensable for industrial high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers in nearly all countries around the world. The Company has a high level of geographic diversification with more than 14,000 employees in 35 main production sites and more than 70 sales offices around the world. RHI Magnesita intends to leverage its global leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

 

Its shares have a premium listing on the London Stock Exchange (symbol: RHIM) and are a constituent of the FTSE 250 index. For more information please visit: www.rhimagnesita.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSFFFMWFUSELU
Date   Source Headline
1st Jun 20268:49 amRNSTotal Voting Rights
13th May 20264:07 pmRNSResult of AGM
1st May 20268:57 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSQ1 Trading Update
1st Apr 20269:11 amRNSTotal Voting Rights
26th Mar 20262:54 pmRNSNotice of AGM
10th Mar 202611:18 amRNSDirector/PDMR Shareholding
2nd Mar 20267:55 amRNSAnnual Financial Report
2nd Mar 20267:49 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNS2025 Full Year Results
13th Feb 20268:56 amRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
10th Dec 20259:10 amRNSDirectorate change
10th Nov 20257:00 amRNSTrading Update
7th Nov 202511:48 amRNSDirectorate change
3rd Nov 202511:54 amRNSDirectorate change
1st Oct 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNS2025 Half Year Results
16th Jul 20257:00 amRNSNotice of Results
30th Jun 20258:29 amRNSDirector Declaration
2nd Jun 20258:53 amRNSTotal Voting Rights
29th May 20259:26 amRNSDirector/PDMR Shareholding
23rd May 20258:12 amRNSDirector Declaration
7th May 20254:11 pmRNSResult of AGM
7th May 20257:00 amRNSQ1 2025 Trading Update
1st May 20259:07 amRNSTotal Voting Rights
7th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20254:17 pmRNSDirector/PDMR Shareholding
1st Apr 20254:49 pmRNSDirector/PDMR Shareholding
1st Apr 20259:13 amRNSTotal Voting Rights
28th Mar 20254:12 pmRNSDirector/PDMR Shareholding
27th Mar 20253:30 pmRNSNotice of AGM
27th Mar 20252:50 pmRNSDirectorate Change
24th Mar 202512:32 pmRNSNotice of AGM
7th Mar 202510:13 amRNS2025 Long Term Incentive Plan Awards
27th Feb 20257:00 amRNS2024 Full Year Results
17th Feb 20257:00 amRNSNotice of Results
3rd Feb 20259:11 amRNSTotal Voting Rights
28th Jan 20251:59 pmRNSCompletion of Resco transaction
2nd Jan 20257:00 amRNSTotal Voting Rights
28th Nov 202410:09 amRNSDirector/PDMR Shareholding
21st Nov 20249:03 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSQ3 2024 Trading Update
7th Oct 202410:10 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSTotal Voting Rights
27th Sep 202411:15 amRNSExercise of LTIP options by PDMR
19th Aug 202410:31 amRNSDirector/PDMR Shareholding
12th Aug 20242:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.